1. Home
  2. CNSP vs MOVE Comparison

CNSP vs MOVE Comparison

Compare CNSP & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNSP
  • MOVE
  • Stock Information
  • Founded
  • CNSP 2017
  • MOVE 2018
  • Country
  • CNSP United States
  • MOVE United States
  • Employees
  • CNSP N/A
  • MOVE N/A
  • Industry
  • CNSP Biotechnology: Pharmaceutical Preparations
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CNSP Health Care
  • MOVE Health Care
  • Exchange
  • CNSP Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • CNSP 5.6M
  • MOVE 5.3M
  • IPO Year
  • CNSP 2019
  • MOVE 2021
  • Fundamental
  • Price
  • CNSP $0.82
  • MOVE $0.69
  • Analyst Decision
  • CNSP Hold
  • MOVE Buy
  • Analyst Count
  • CNSP 1
  • MOVE 1
  • Target Price
  • CNSP N/A
  • MOVE $30.00
  • AVG Volume (30 Days)
  • CNSP 212.8K
  • MOVE 247.0K
  • Earning Date
  • CNSP 08-13-2025
  • MOVE 08-13-2025
  • Dividend Yield
  • CNSP N/A
  • MOVE N/A
  • EPS Growth
  • CNSP N/A
  • MOVE N/A
  • EPS
  • CNSP N/A
  • MOVE N/A
  • Revenue
  • CNSP N/A
  • MOVE $1,013,000.00
  • Revenue This Year
  • CNSP N/A
  • MOVE $1,460.71
  • Revenue Next Year
  • CNSP N/A
  • MOVE $96.77
  • P/E Ratio
  • CNSP N/A
  • MOVE N/A
  • Revenue Growth
  • CNSP N/A
  • MOVE N/A
  • 52 Week Low
  • CNSP $0.73
  • MOVE $0.51
  • 52 Week High
  • CNSP $148.00
  • MOVE $6.97
  • Technical
  • Relative Strength Index (RSI)
  • CNSP 39.83
  • MOVE 44.63
  • Support Level
  • CNSP $0.73
  • MOVE $0.67
  • Resistance Level
  • CNSP $0.90
  • MOVE $0.85
  • Average True Range (ATR)
  • CNSP 0.07
  • MOVE 0.09
  • MACD
  • CNSP 0.01
  • MOVE 0.01
  • Stochastic Oscillator
  • CNSP 46.48
  • MOVE 25.04

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: